Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Jon H, Meyerle"'
Publikováno v:
Journal of the American Academy of Dermatology. 86:237-239
Publikováno v:
Current Dermatology Reports. 10:33-39
This review summarizes the history and usage of teledermatology in the US Military and potential directions in the future. Given the remote and austere environment that operational settings present, it is hard to provide specialized medical care for
Publikováno v:
Military Medicine. 187:e624-e629
Introduction Skin malignancy has increased in prevalence over the last 15 years and effective diagnosis is required for adequate treatment. Retrospective data analysis of skin biopsy data has shown correlation between various independent variables, b
Autor:
Jessica L. Naff, Alexandra F. Freeman, Keiko Sakamoto, Heidi H. Kong, Ijeoma D. Ikpeama, Sergio D. Rosenzweig, Do Young Kim, Gary A. Fahle, Benjamin Voisin, Michael C. Kelly, Julie Alejo, Tetsuro Kobayashi, Fred P. Davis, Keisuke Nagao, Jay-Hyun Jo, Jon H. Meyerle, Seon-Pil Jin, Stefania Pittaluga, Helena B. Pasieka
Publikováno v:
Nature Medicine. 26:236-243
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DiHS/DRESS) is a potentially fatal multiorgan inflammatory disease associated with herpesvirus reactivation and subsequent onset of autoimmune diseases1-4.
Publikováno v:
Dermatologic Surgery. 46:1466-1468
Autor:
Kaitlyn Schiavone, Marcedes Coffman, Gabrielle Schwartzman, Meagan McGinley Simpson, Jon H. Meyerle, Ryan M Jones
Publikováno v:
Cutis. 105
Anti-programmed cell death 1 (PD1) targeted immune checkpoint inhibitors such as nivolumab and pembrolizumab are increasingly used to treat advanced malignancies such as melanoma, non-small cell lung cancer, urothelial cancer, and renal cell carcinom
Autor:
Jon H. Meyerle, Alexandra Rosenberg
Publikováno v:
Military Medicine. 182:1628-1631
Psoriasis is a chronic immune-mediated dermatologic disorder affecting approximately 2% of the general population. Under current U.S. Army regulation, the diagnosis of psoriasis is a bar to enlistment or appointment and, if poorly controlled, is grou
Publikováno v:
Cutis. 103(6)
Unfractionated heparin (UFH) is frequently used in the treatment of venous thromboembolism and acute coronary syndrome. There are many common cutaneous adverse reactions to this medication. We present a unique case of hemorrhagic bullae limited to th
Publikováno v:
Cutis. 103(6)
Bullous systemic lupus erythematosus (BSLE) is a rare complication of systemic lupus erythematosus (SLE) characterized by cutaneous vesicles and bullae with a primarily neutrophilic infiltrate on histopathology. Bullous SLE is a heterogeneous disease
Autor:
Ford M, Lannan, Jon H, Meyerle
Publikováno v:
Cutis. 103(2)
Amputees face many challenges associated with residual limbs. Overall, amputees have an increased risk for skin disease occurring at residual limb sites. Although prosthetists and primary care physicians often accomplish routine care, the dermatologi